Vinbarbital
| Vinbarbital | |
|---|---|
| Vinbarbital_skeletal.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Vinbarbital is a barbiturate derivative that has been used primarily as a sedative and hypnotic. It is a central nervous system depressant that works by enhancing the effects of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor.
Pharmacology[edit]
Vinbarbital, like other barbiturates, acts on the central nervous system to produce a range of effects from mild sedation to full anesthesia. It enhances the inhibitory effects of GABA, leading to increased chloride ion conductance and hyperpolarization of neurons.
Medical uses[edit]
Vinbarbital has been used in the past for its sedative and hypnotic properties. It was prescribed to treat insomnia, anxiety, and sometimes used as a pre-anesthetic agent.
Side effects[edit]
Common side effects of vinbarbital include drowsiness, dizziness, and ataxia. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon cessation.
History[edit]
Vinbarbital was developed in the early 20th century as part of the class of barbiturates, which were widely used before the advent of benzodiazepines.
Chemical structure[edit]
Vinbarbital is chemically related to other barbiturates, sharing the core structure of a barbituric acid derivative with modifications that affect its pharmacokinetic and pharmacodynamic properties.
